Exosomes as the source of biomarkers of metabolic diseases
Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent , and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diab...
Saved in:
Published in | Annals of pediatric endocrinology & metabolism Vol. 21; no. 3; pp. 119 - 125 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society of Pediatric Endocrinology
01.09.2016
Korean Society of Pediatric Endocrinology 대한소아내분비학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2287-1012 2287-1292 |
DOI | 10.6065/apem.2016.21.3.119 |
Cover
Abstract | Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent
,
and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism. |
---|---|
AbstractList | Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism.Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism. Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism. KCI Citation Count: 0 Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism. Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro , in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism. Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent , and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism. |
Author | Park, Dong-Ho Lee, Min-Jae Kang, Ju-Hee |
AuthorAffiliation | 1 Department of Pharmacology and Medicinal Toxicology Research Center, Inha University School of Medicine, Incheon, Korea 2 Department of Kinesiology, College of Arts and Sports, Inha University School of Medicine, Incheon, Korea 3 Hypoxia-related Disease Research Center, Inha University School of Medicine, Incheon, Korea |
AuthorAffiliation_xml | – name: 1 Department of Pharmacology and Medicinal Toxicology Research Center, Inha University School of Medicine, Incheon, Korea – name: 3 Hypoxia-related Disease Research Center, Inha University School of Medicine, Incheon, Korea – name: 2 Department of Kinesiology, College of Arts and Sports, Inha University School of Medicine, Incheon, Korea |
Author_xml | – sequence: 1 givenname: Min-Jae surname: Lee fullname: Lee, Min-Jae organization: Department of Pharmacology and Medicinal Toxicology Research Center, Inha University School of Medicine, Incheon, Korea., Department of Kinesiology, College of Arts and Sports, Inha University School of Medicine, Incheon, Korea – sequence: 2 givenname: Dong-Ho surname: Park fullname: Park, Dong-Ho organization: Department of Kinesiology, College of Arts and Sports, Inha University School of Medicine, Incheon, Korea – sequence: 3 givenname: Ju-Hee surname: Kang fullname: Kang, Ju-Hee organization: Department of Pharmacology and Medicinal Toxicology Research Center, Inha University School of Medicine, Incheon, Korea., Hypoxia-related Disease Research Center, Inha University School of Medicine, Incheon, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27777903$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002152674$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kk1v1DAQhi1URD_oH-CAcoTDBo-dxDYHpKpqYaVKSKicLdsZt-4m8WJnK_j3eHe7iHLAl_HH-z5jj-eUHE1xQkLeAK072rUfzBrHmlHoagY1rwHUC3LCmBQLYIodHeYU2DE5z_mBliEo67h8RY6ZKENRfkI-Xv2MOY6YK5Or-R6rHDfJYRV9ZUMcTVphytvViLOxcQiu6kNGkzG_Ji-9GTKeP8Uz8v366vbyy-Lm6-fl5cXNwrUtVwvjhZcKfd96RNsLkJwzR5nwvmkakH2D4JS0IGSDqu-6ngKnjeKMFlvn-Rl5v-dOyeuVCzqasIt3Ua-Svvh2u9QAwBjwol3utX00D3qdQnnBr51htxHTnTZpDm5A3XppmWl8wy1tmGwl9p0w0jhnJVJrC-vTnrXe2BF7h9OczPAM-vxkCvflTo-6pYJDKwrg3RMgxR8bzLMeQ3Y4DGbCuMm6VKJUqKVKFunbv3P9SXL4qCKQe4FLMeeEXrswmznEbeowaKB62xZ62xZ62xaagealLqpY2T_WA_0_pt-eDbrf |
CitedBy_id | crossref_primary_10_1080_02713683_2020_1797107 crossref_primary_10_1111_aji_12788 crossref_primary_10_1080_20013078_2018_1473707 crossref_primary_10_1007_s12015_022_10342_y crossref_primary_10_1007_s00210_024_03762_9 crossref_primary_10_1016_j_ncrna_2020_03_001 crossref_primary_10_2147_NSS_S310351 crossref_primary_10_1007_s40291_020_00493_4 crossref_primary_10_1016_j_lfs_2019_116861 crossref_primary_10_1021_acssensors_3c00689 crossref_primary_10_1039_D1NA00330E crossref_primary_10_1038_s41598_019_50244_7 crossref_primary_10_1088_1361_6528_abba58 crossref_primary_10_1096_fj_201700417R crossref_primary_10_1128_mSphere_00030_18 crossref_primary_10_35118_apjmbb_2020_028_1_03 crossref_primary_10_1016_j_theriogenology_2018_03_024 crossref_primary_10_3233_CBM_170727 crossref_primary_10_18632_oncotarget_24809 crossref_primary_10_1007_s12265_020_09966_7 crossref_primary_10_3390_ijms19113383 crossref_primary_10_1080_10408363_2022_2027864 crossref_primary_10_1210_endocr_bqab032 crossref_primary_10_1093_molehr_gay019 crossref_primary_10_1038_s41598_017_05541_4 crossref_primary_10_1007_s40200_019_00404_3 crossref_primary_10_1016_j_metabol_2021_154727 crossref_primary_10_1080_15384101_2019_1638694 crossref_primary_10_1007_s00441_023_03802_5 crossref_primary_10_1080_14789450_2017_1364629 crossref_primary_10_18502_wkmj_v66i4_17768 crossref_primary_10_3390_ijms18030456 crossref_primary_10_1007_s10529_023_03430_7 crossref_primary_10_1038_s41598_020_75561_0 crossref_primary_10_3389_fbioe_2022_1019821 crossref_primary_10_3390_cancers14122826 crossref_primary_10_1016_j_trsl_2018_01_005 |
Cites_doi | 10.1038/nrendo.2016.76 10.1016/j.jss.2014.06.050 10.1038/srep21447 10.4049/jimmunol.1103466 10.1002/bies.201100169 10.1038/nrd3978 10.1016/j.tem.2016.03.012 10.1371/journal.pone.0027809 10.3402/jev.v3.24858 10.1021/pr8004887 10.1016/j.yexcr.2010.04.006 10.1016/j.jprot.2013.10.037 10.1111/j.1751-7176.2012.00631.x 10.1210/en.2006-1479 10.1093/eurheartj/ehq167 10.1016/j.atherosclerosis.2009.06.037 10.1007/s00125-016-3882-y 10.2337/db09-0216 10.1562/0031-8655(2003)078<0241:CACACB>2.0.CO;2 10.1161/01.CIR.0000036596.59665.C6 10.1186/1475-2840-13-37 10.1038/ncb1132 10.1038/ncb2502 10.3402/jev.v3.26913 10.1016/j.jalz.2014.06.008 10.1177/1479164111434318 10.1038/nature07961 10.1093/eurheartj/ehu153 10.1007/s00125-014-3337-2 10.1016/j.addr.2010.06.001 10.1016/j.scr.2011.01.001 10.1681/ASN.2013070763 10.1111/j.1600-0854.2007.00566.x 10.1007/s12265-011-9296-9 10.3402/jev.v5.29289 10.1016/j.semcancer.2014.04.009 10.1093/aje/kwh281 10.1007/s00401-014-1314-y 10.1530/JOE-15-0201 10.1523/JNEUROSCI.5699-09.2010 10.3402/jev.v2i0.20360 10.1007/s10930-015-9616-z 10.4049/jimmunol.180.2.817 10.3402/jev.v4.27031 10.2353/ajpath.2008.080228 10.1371/journal.pone.0037036 10.1210/jc.2013-3843 10.1161/CIRCULATIONAHA.113.001720 10.1016/j.yjmcc.2014.05.001 10.1371/journal.pone.0003377 10.1002/pmic.201300282 10.3389/fphys.2012.00145 10.2217/rme.11.35 10.3402/jev.v4.29509 10.3389/fphys.2012.00124 10.1038/ijo.2011.115 10.1067/mcp.2001.113989 |
ContentType | Journal Article |
Copyright | 2016 Annals of Pediatric Endocrinology & Metabolism |
Copyright_xml | – notice: 2016 Annals of Pediatric Endocrinology & Metabolism |
DBID | AAYXX CITATION NPM 7X8 5PM DOA ACYCR |
DOI | 10.6065/apem.2016.21.3.119 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2287-1292 |
EndPage | 125 |
ExternalDocumentID | oai_kci_go_kr_ARTI_1112213 oai_doaj_org_article_5f8b2a4f43b042858ed67a8accb8e0bb PMC5073157 27777903 10_6065_apem_2016_21_3_119 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: ; |
GroupedDBID | 5-W 8JR 8XY AAYXX ABDBF ACUHS ADBBV ADRAZ AEGXH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EF. GROUPED_DOAJ GX1 HYE IPNFZ KQ8 M48 OK1 PGMZT RIG RPM NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c5539-af7f89efd5feebd718332c027ff44418d4e1c98b1784e9d66d01304932089e6f3 |
IEDL.DBID | M48 |
ISSN | 2287-1012 |
IngestDate | Tue Nov 21 21:39:42 EST 2023 Wed Aug 27 01:24:10 EDT 2025 Thu Aug 21 18:40:14 EDT 2025 Fri Jul 11 06:22:26 EDT 2025 Thu Jan 02 22:21:17 EST 2025 Tue Jul 01 03:45:54 EDT 2025 Thu Apr 24 23:01:49 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Biomarkers Metabolic syndrome X Exosomes Diabetes mellitus Standardization |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5539-af7f89efd5feebd718332c027ff44418d4e1c98b1784e9d66d01304932089e6f3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 G704-002175.2016.21.3.010 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.6065/apem.2016.21.3.119 |
PMID | 27777903 |
PQID | 1835535098 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1112213 doaj_primary_oai_doaj_org_article_5f8b2a4f43b042858ed67a8accb8e0bb pubmedcentral_primary_oai_pubmedcentral_nih_gov_5073157 proquest_miscellaneous_1835535098 pubmed_primary_27777903 crossref_citationtrail_10_6065_apem_2016_21_3_119 crossref_primary_10_6065_apem_2016_21_3_119 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-09-01 |
PublicationDateYYYYMMDD | 2016-09-01 |
PublicationDate_xml | – month: 09 year: 2016 text: 2016-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Annals of pediatric endocrinology & metabolism |
PublicationTitleAlternate | Ann Pediatr Endocrinol Metab |
PublicationYear | 2016 |
Publisher | The Korean Society of Pediatric Endocrinology Korean Society of Pediatric Endocrinology 대한소아내분비학회 |
Publisher_xml | – name: The Korean Society of Pediatric Endocrinology – name: Korean Society of Pediatric Endocrinology – name: 대한소아내분비학회 |
References | Quesenberry (10.6065/apem.2016.21.3.119_ref11) 2010; 62 Santovito (10.6065/apem.2016.21.3.119_ref29) 2014; 99 Livshits (10.6065/apem.2016.21.3.119_ref39) 2016; 6 Diamant (10.6065/apem.2016.21.3.119_ref21) 2002; 106 Emmanouilidou (10.6065/apem.2016.21.3.119_ref18) 2010; 30 Shi (10.6065/apem.2016.21.3.119_ref48) 2014; 128 Feng (10.6065/apem.2016.21.3.119_ref23) 2010; 208 Wang (10.6065/apem.2016.21.3.119_ref32) 2014; 74 Koeck (10.6065/apem.2016.21.3.119_ref36) 2014; 192 Kim (10.6065/apem.2016.21.3.119_ref24) 2012; 7 Hong (10.6065/apem.2016.21.3.119_ref46) 2016; 5 Deng (10.6065/apem.2016.21.3.119_ref30) 2009; 58 O'Neill (10.6065/apem.2016.21.3.119_ref33) 2016; 27 Lee (10.6065/apem.2016.21.3.119_ref28) 2015; 34 Cai (10.6065/apem.2016.21.3.119_ref16) 2012; 188 Chivet (10.6065/apem.2016.21.3.119_ref9) 2012; 3 Van Deun (10.6065/apem.2016.21.3.119_ref44) 2014; 3 Conde-Vancells (10.6065/apem.2016.21.3.119_ref3) 2008; 7 Lobb (10.6065/apem.2016.21.3.119_ref49) 2015; 4 Kanhai (10.6065/apem.2016.21.3.119_ref38) 2012; 36 Lai (10.6065/apem.2016.21.3.119_ref12) 2011; 6 Sun (10.6065/apem.2016.21.3.119_ref56) 2012; 9 EL Andaloussi (10.6065/apem.2016.21.3.119_ref7) 2013; 12 Cocucci (10.6065/apem.2016.21.3.119_ref40) 2007; 8 Guescini (10.6065/apem.2016.21.3.119_ref1) 2010; 316 Aoki (10.6065/apem.2016.21.3.119_ref2) 2007; 148 Zubiri (10.6065/apem.2016.21.3.119_ref57) 2014; 96 Jang (10.6065/apem.2016.21.3.119_ref10) 2004; 6 Lawson (10.6065/apem.2016.21.3.119_ref35) 2016; 228 Camussi (10.6065/apem.2016.21.3.119_ref14) 2011; 1 Simhadri (10.6065/apem.2016.21.3.119_ref8) 2008; 3 Linares (10.6065/apem.2016.21.3.119_ref43) 2015; 4 Witwer (10.6065/apem.2016.21.3.119_ref58) 2013; 2 Timmers (10.6065/apem.2016.21.3.119_ref13) 2011; 6 Jalabert (10.6065/apem.2016.21.3.119_ref27) 2016; 59 Rak (10.6065/apem.2016.21.3.119_ref15) 2012; 34 Jayachandran (10.6065/apem.2016.21.3.119_ref20) 2011; 4 Kranendonk (10.6065/apem.2016.21.3.119_ref54) 2014; 13 Agouni (10.6065/apem.2016.21.3.119_ref51) 2008; 173 Jansen (10.6065/apem.2016.21.3.119_ref31) 2013; 128 Ogata (10.6065/apem.2016.21.3.119_ref25) 2003; 78 Amabile (10.6065/apem.2016.21.3.119_ref52) 2014; 35 Kalra (10.6065/apem.2016.21.3.119_ref45) 2013; 13 Bellingham (10.6065/apem.2016.21.3.119_ref17) 2012; 3 Nicklas (10.6065/apem.2016.21.3.119_ref37) 2004; 160 Eken (10.6065/apem.2016.21.3.119_ref41) 2008; 180 Fiandaca (10.6065/apem.2016.21.3.119_ref47) 2015; 11 Villarroya-Beltri (10.6065/apem.2016.21.3.119_ref6) 2014; 28 Agouni (10.6065/apem.2016.21.3.119_ref50) 2011; 6 Raiborg (10.6065/apem.2016.21.3.119_ref4) 2009; 458 Baietti (10.6065/apem.2016.21.3.119_ref5) 2012; 14 Biomarkers Definitions Working Group (10.6065/apem.2016.21.3.119_ref34) 2001; 69 Safdar (10.6065/apem.2016.21.3.119_ref26) 2016; 12 Burger (10.6065/apem.2016.21.3.119_ref55) 2014; 25 Aswad (10.6065/apem.2016.21.3.119_ref19) 2014; 57 D'Alessandra (10.6065/apem.2016.21.3.119_ref22) 2010; 31 Lötvall (10.6065/apem.2016.21.3.119_ref42) 2014; 3 Chen (10.6065/apem.2016.21.3.119_ref53) 2012; 14 19675137 - Diabetes. 2009 Nov;58(11):2498-505 22442051 - Bioessays. 2012 Jun;34(6):489-97 26194179 - J Extracell Vesicles. 2015 Jul 17;4:27031 25317274 - J Extracell Vesicles. 2014 Sep 18;3:null 20484626 - J Neurosci. 2010 May 19;30(20):6838-51 27230949 - Nat Rev Endocrinol. 2016 Sep;12(9):504-17 15466496 - Am J Epidemiol. 2004 Oct 15;160(8):741-9 12417540 - Circulation. 2002 Nov 5;106(19):2442-7 24997849 - Acta Neuropathol. 2014 Nov;128(5):639-50 24676640 - J Am Soc Nephrol. 2014 Jul;25(7):1401-7 21786187 - J Cardiovasc Transl Res. 2011 Dec;4(6):811-22 22660413 - Nat Cell Biol. 2012 Jun 03;14(7):677-85 21969178 - Am J Cancer Res. 2011;1(1):98-110 24211404 - J Proteomics. 2014 Jan 16;96:92-102 17478559 - Endocrinology. 2007 Aug;148(8):3850-62 22563321 - Front Physiol. 2012 May 03;3:124 19674745 - Atherosclerosis. 2010 Jan;208(1):264-9 24009894 - J Extracell Vesicles. 2013 May 27;2:null 22747618 - J Clin Hypertens (Greenwich). 2012 Jul;14(7):455-60 23584393 - Nat Rev Drug Discov. 2013 May;12(5):347-57 21419744 - Stem Cell Res. 2011 May;6(3):206-14 25130657 - Alzheimers Dement. 2015 Jun;11(6):600-7.e1 14556310 - Photochem Photobiol. 2003 Sep;78(3):241-7 26743452 - J Endocrinol. 2016 Feb;228(2):R57-71 24937531 - J Clin Endocrinol Metab. 2014 Sep;99(9):E1681-5 22654762 - Front Physiol. 2012 May 28;3:145 20558219 - Adv Drug Deliv Rev. 2010 Sep 30;62(12):1141-8 19367702 - J Proteome Res. 2008 Dec;7(12):5157-66 24742886 - Eur Heart J. 2014 Nov 7;35(42):2972-9 20534597 - Eur Heart J. 2010 Nov;31(22):2765-73 25998041 - Protein J. 2015 Jun;34(3):220-35 25073444 - Diabetologia. 2014 Oct;57(10):2155-64 27018366 - J Extracell Vesicles. 2016 Mar 24;5:29289 24769058 - Semin Cancer Biol. 2014 Oct;28:3-13 18852879 - PLoS One. 2008;3(10):e3377 27022711 - Sci Rep. 2016 Mar 29;6:21447 27150849 - Trends Endocrinol Metab. 2016 Jun;27(6):363-74 26700615 - J Extracell Vesicles. 2015 Dec 23;4:29509 17488290 - Traffic. 2007 Jun;8(6):742-57 15133469 - Nat Cell Biol. 2004 Jun;6(6):532-9 25086727 - J Surg Res. 2014 Dec;192(2):268-75 24825548 - J Mol Cell Cardiol. 2014 Sep;74:139-50 11240971 - Clin Pharmacol Ther. 2001 Mar;69(3):89-95 21749206 - Regen Med. 2011 Jul;6(4):481-92 22573809 - J Immunol. 2012 Jun 15;188(12):5954-61 19325624 - Nature. 2009 Mar 26;458(7237):445-52 22110764 - PLoS One. 2011;6(11):e27809 26852333 - Diabetologia. 2016 May;59(5):1049-58 24498934 - Cardiovasc Diabetol. 2014 Feb 05;13:37 20399774 - Exp Cell Res. 2010 Jul 15;316(12):1977-84 18178820 - J Immunol. 2008 Jan 15;180(2):817-24 25536934 - J Extracell Vesicles. 2014 Dec 22;3:26913 24014835 - Circulation. 2013 Oct 29;128(18):2026-38 24115447 - Proteomics. 2013 Nov;13(22):3354-64 18772329 - Am J Pathol. 2008 Oct;173(4):1210-9 21712810 - Int J Obes (Lond). 2012 May;36(5):695-702 22388283 - Diab Vasc Dis Res. 2012 Oct;9(4):301-8 22615882 - PLoS One. 2012;7(5):e37036 |
References_xml | – volume: 12 start-page: 504 year: 2016 ident: 10.6065/apem.2016.21.3.119_ref26 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2016.76 – volume: 192 start-page: 268 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref36 publication-title: J Surg Res doi: 10.1016/j.jss.2014.06.050 – volume: 6 start-page: 21447 year: 2016 ident: 10.6065/apem.2016.21.3.119_ref39 publication-title: Sci Rep doi: 10.1038/srep21447 – volume: 188 start-page: 5954 year: 2012 ident: 10.6065/apem.2016.21.3.119_ref16 publication-title: J Immunol doi: 10.4049/jimmunol.1103466 – volume: 34 start-page: 489 year: 2012 ident: 10.6065/apem.2016.21.3.119_ref15 publication-title: Bioessays doi: 10.1002/bies.201100169 – volume: 12 start-page: 347 year: 2013 ident: 10.6065/apem.2016.21.3.119_ref7 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd3978 – volume: 27 start-page: 363 year: 2016 ident: 10.6065/apem.2016.21.3.119_ref33 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2016.03.012 – volume: 6 start-page: e27809 year: 2011 ident: 10.6065/apem.2016.21.3.119_ref50 publication-title: PLoS One doi: 10.1371/journal.pone.0027809 – volume: 3 start-page: 24858 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref44 publication-title: J Extracell Vesicles doi: 10.3402/jev.v3.24858 – volume: 7 start-page: 5157 year: 2008 ident: 10.6065/apem.2016.21.3.119_ref3 publication-title: J Proteome Res doi: 10.1021/pr8004887 – volume: 316 start-page: 1977 year: 2010 ident: 10.6065/apem.2016.21.3.119_ref1 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2010.04.006 – volume: 96 start-page: 92 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref57 publication-title: J Proteomics doi: 10.1016/j.jprot.2013.10.037 – volume: 14 start-page: 455 year: 2012 ident: 10.6065/apem.2016.21.3.119_ref53 publication-title: J Clin Hypertens (Greenwich) doi: 10.1111/j.1751-7176.2012.00631.x – volume: 148 start-page: 3850 year: 2007 ident: 10.6065/apem.2016.21.3.119_ref2 publication-title: Endocrinology doi: 10.1210/en.2006-1479 – volume: 31 start-page: 2765 year: 2010 ident: 10.6065/apem.2016.21.3.119_ref22 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehq167 – volume: 208 start-page: 264 year: 2010 ident: 10.6065/apem.2016.21.3.119_ref23 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2009.06.037 – volume: 59 start-page: 1049 year: 2016 ident: 10.6065/apem.2016.21.3.119_ref27 publication-title: Diabetologia doi: 10.1007/s00125-016-3882-y – volume: 58 start-page: 2498 year: 2009 ident: 10.6065/apem.2016.21.3.119_ref30 publication-title: Diabetes doi: 10.2337/db09-0216 – volume: 78 start-page: 241 year: 2003 ident: 10.6065/apem.2016.21.3.119_ref25 publication-title: Photochem Photobiol doi: 10.1562/0031-8655(2003)078<0241:CACACB>2.0.CO;2 – volume: 106 start-page: 2442 year: 2002 ident: 10.6065/apem.2016.21.3.119_ref21 publication-title: Circulation doi: 10.1161/01.CIR.0000036596.59665.C6 – volume: 13 start-page: 37 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref54 publication-title: Cardiovasc Diabetol doi: 10.1186/1475-2840-13-37 – volume: 6 start-page: 532 year: 2004 ident: 10.6065/apem.2016.21.3.119_ref10 publication-title: Nat Cell Biol doi: 10.1038/ncb1132 – volume: 14 start-page: 677 year: 2012 ident: 10.6065/apem.2016.21.3.119_ref5 publication-title: Nat Cell Biol doi: 10.1038/ncb2502 – volume: 3 start-page: 26913 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref42 publication-title: J Extracell Vesicles doi: 10.3402/jev.v3.26913 – volume: 11 start-page: 600 year: 2015 ident: 10.6065/apem.2016.21.3.119_ref47 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2014.06.008 – volume: 9 start-page: 301 year: 2012 ident: 10.6065/apem.2016.21.3.119_ref56 publication-title: Diab Vasc Dis Res doi: 10.1177/1479164111434318 – volume: 1 start-page: 98 year: 2011 ident: 10.6065/apem.2016.21.3.119_ref14 publication-title: Am J Cancer Res – volume: 458 start-page: 445 year: 2009 ident: 10.6065/apem.2016.21.3.119_ref4 publication-title: Nature doi: 10.1038/nature07961 – volume: 35 start-page: 2972 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref52 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu153 – volume: 57 start-page: 2155 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref19 publication-title: Diabetologia doi: 10.1007/s00125-014-3337-2 – volume: 62 start-page: 1141 year: 2010 ident: 10.6065/apem.2016.21.3.119_ref11 publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2010.06.001 – volume: 6 start-page: 206 year: 2011 ident: 10.6065/apem.2016.21.3.119_ref13 publication-title: Stem Cell Res doi: 10.1016/j.scr.2011.01.001 – volume: 25 start-page: 1401 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref55 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2013070763 – volume: 8 start-page: 742 year: 2007 ident: 10.6065/apem.2016.21.3.119_ref40 publication-title: Traffic doi: 10.1111/j.1600-0854.2007.00566.x – volume: 4 start-page: 811 year: 2011 ident: 10.6065/apem.2016.21.3.119_ref20 publication-title: J Cardiovasc Transl Res doi: 10.1007/s12265-011-9296-9 – volume: 5 start-page: 29289 year: 2016 ident: 10.6065/apem.2016.21.3.119_ref46 publication-title: J Extracell Vesicles doi: 10.3402/jev.v5.29289 – volume: 28 start-page: 3 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref6 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2014.04.009 – volume: 160 start-page: 741 year: 2004 ident: 10.6065/apem.2016.21.3.119_ref37 publication-title: Am J Epidemiol doi: 10.1093/aje/kwh281 – volume: 128 start-page: 639 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref48 publication-title: Acta Neuropathol doi: 10.1007/s00401-014-1314-y – volume: 228 start-page: R57 year: 2016 ident: 10.6065/apem.2016.21.3.119_ref35 publication-title: J Endocrinol doi: 10.1530/JOE-15-0201 – volume: 30 start-page: 6838 year: 2010 ident: 10.6065/apem.2016.21.3.119_ref18 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5699-09.2010 – volume: 2 start-page: 20360 year: 2013 ident: 10.6065/apem.2016.21.3.119_ref58 publication-title: J Extracell Vesicles doi: 10.3402/jev.v2i0.20360 – volume: 34 start-page: 220 year: 2015 ident: 10.6065/apem.2016.21.3.119_ref28 publication-title: Protein J doi: 10.1007/s10930-015-9616-z – volume: 180 start-page: 817 year: 2008 ident: 10.6065/apem.2016.21.3.119_ref41 publication-title: J Immunol doi: 10.4049/jimmunol.180.2.817 – volume: 4 start-page: 27031 year: 2015 ident: 10.6065/apem.2016.21.3.119_ref49 publication-title: J Extracell Vesicles doi: 10.3402/jev.v4.27031 – volume: 173 start-page: 1210 year: 2008 ident: 10.6065/apem.2016.21.3.119_ref51 publication-title: Am J Pathol doi: 10.2353/ajpath.2008.080228 – volume: 7 start-page: e37036 year: 2012 ident: 10.6065/apem.2016.21.3.119_ref24 publication-title: PLoS One doi: 10.1371/journal.pone.0037036 – volume: 99 start-page: E1681 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref29 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-3843 – volume: 128 start-page: 2026 year: 2013 ident: 10.6065/apem.2016.21.3.119_ref31 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.001720 – volume: 74 start-page: 139 year: 2014 ident: 10.6065/apem.2016.21.3.119_ref32 publication-title: J Mol Cell Cardiol doi: 10.1016/j.yjmcc.2014.05.001 – volume: 3 start-page: e3377 year: 2008 ident: 10.6065/apem.2016.21.3.119_ref8 publication-title: PLoS One doi: 10.1371/journal.pone.0003377 – volume: 13 start-page: 3354 year: 2013 ident: 10.6065/apem.2016.21.3.119_ref45 publication-title: Proteomics doi: 10.1002/pmic.201300282 – volume: 3 start-page: 145 year: 2012 ident: 10.6065/apem.2016.21.3.119_ref9 publication-title: Front Physiol doi: 10.3389/fphys.2012.00145 – volume: 6 start-page: 481 year: 2011 ident: 10.6065/apem.2016.21.3.119_ref12 publication-title: Regen Med doi: 10.2217/rme.11.35 – volume: 4 start-page: 29509 year: 2015 ident: 10.6065/apem.2016.21.3.119_ref43 publication-title: J Extracell Vesicles doi: 10.3402/jev.v4.29509 – volume: 3 start-page: 124 year: 2012 ident: 10.6065/apem.2016.21.3.119_ref17 publication-title: Front Physiol doi: 10.3389/fphys.2012.00124 – volume: 36 start-page: 695 year: 2012 ident: 10.6065/apem.2016.21.3.119_ref38 publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2011.115 – volume: 69 start-page: 89 year: 2001 ident: 10.6065/apem.2016.21.3.119_ref34 publication-title: Clin Pharmacol Ther doi: 10.1067/mcp.2001.113989 – reference: 18852879 - PLoS One. 2008;3(10):e3377 – reference: 19675137 - Diabetes. 2009 Nov;58(11):2498-505 – reference: 24211404 - J Proteomics. 2014 Jan 16;96:92-102 – reference: 19674745 - Atherosclerosis. 2010 Jan;208(1):264-9 – reference: 11240971 - Clin Pharmacol Ther. 2001 Mar;69(3):89-95 – reference: 20399774 - Exp Cell Res. 2010 Jul 15;316(12):1977-84 – reference: 22660413 - Nat Cell Biol. 2012 Jun 03;14(7):677-85 – reference: 18772329 - Am J Pathol. 2008 Oct;173(4):1210-9 – reference: 26743452 - J Endocrinol. 2016 Feb;228(2):R57-71 – reference: 24769058 - Semin Cancer Biol. 2014 Oct;28:3-13 – reference: 19367702 - J Proteome Res. 2008 Dec;7(12):5157-66 – reference: 15466496 - Am J Epidemiol. 2004 Oct 15;160(8):741-9 – reference: 25998041 - Protein J. 2015 Jun;34(3):220-35 – reference: 24014835 - Circulation. 2013 Oct 29;128(18):2026-38 – reference: 20534597 - Eur Heart J. 2010 Nov;31(22):2765-73 – reference: 22388283 - Diab Vasc Dis Res. 2012 Oct;9(4):301-8 – reference: 24937531 - J Clin Endocrinol Metab. 2014 Sep;99(9):E1681-5 – reference: 18178820 - J Immunol. 2008 Jan 15;180(2):817-24 – reference: 22654762 - Front Physiol. 2012 May 28;3:145 – reference: 25317274 - J Extracell Vesicles. 2014 Sep 18;3:null – reference: 22747618 - J Clin Hypertens (Greenwich). 2012 Jul;14(7):455-60 – reference: 24676640 - J Am Soc Nephrol. 2014 Jul;25(7):1401-7 – reference: 25073444 - Diabetologia. 2014 Oct;57(10):2155-64 – reference: 22563321 - Front Physiol. 2012 May 03;3:124 – reference: 20558219 - Adv Drug Deliv Rev. 2010 Sep 30;62(12):1141-8 – reference: 24825548 - J Mol Cell Cardiol. 2014 Sep;74:139-50 – reference: 24115447 - Proteomics. 2013 Nov;13(22):3354-64 – reference: 24498934 - Cardiovasc Diabetol. 2014 Feb 05;13:37 – reference: 27150849 - Trends Endocrinol Metab. 2016 Jun;27(6):363-74 – reference: 15133469 - Nat Cell Biol. 2004 Jun;6(6):532-9 – reference: 22442051 - Bioessays. 2012 Jun;34(6):489-97 – reference: 22615882 - PLoS One. 2012;7(5):e37036 – reference: 26700615 - J Extracell Vesicles. 2015 Dec 23;4:29509 – reference: 17478559 - Endocrinology. 2007 Aug;148(8):3850-62 – reference: 14556310 - Photochem Photobiol. 2003 Sep;78(3):241-7 – reference: 27022711 - Sci Rep. 2016 Mar 29;6:21447 – reference: 12417540 - Circulation. 2002 Nov 5;106(19):2442-7 – reference: 21749206 - Regen Med. 2011 Jul;6(4):481-92 – reference: 27018366 - J Extracell Vesicles. 2016 Mar 24;5:29289 – reference: 23584393 - Nat Rev Drug Discov. 2013 May;12(5):347-57 – reference: 22110764 - PLoS One. 2011;6(11):e27809 – reference: 22573809 - J Immunol. 2012 Jun 15;188(12):5954-61 – reference: 25086727 - J Surg Res. 2014 Dec;192(2):268-75 – reference: 25536934 - J Extracell Vesicles. 2014 Dec 22;3:26913 – reference: 21419744 - Stem Cell Res. 2011 May;6(3):206-14 – reference: 20484626 - J Neurosci. 2010 May 19;30(20):6838-51 – reference: 21786187 - J Cardiovasc Transl Res. 2011 Dec;4(6):811-22 – reference: 24997849 - Acta Neuropathol. 2014 Nov;128(5):639-50 – reference: 24009894 - J Extracell Vesicles. 2013 May 27;2:null – reference: 21969178 - Am J Cancer Res. 2011;1(1):98-110 – reference: 25130657 - Alzheimers Dement. 2015 Jun;11(6):600-7.e1 – reference: 17488290 - Traffic. 2007 Jun;8(6):742-57 – reference: 26852333 - Diabetologia. 2016 May;59(5):1049-58 – reference: 26194179 - J Extracell Vesicles. 2015 Jul 17;4:27031 – reference: 21712810 - Int J Obes (Lond). 2012 May;36(5):695-702 – reference: 19325624 - Nature. 2009 Mar 26;458(7237):445-52 – reference: 24742886 - Eur Heart J. 2014 Nov 7;35(42):2972-9 – reference: 27230949 - Nat Rev Endocrinol. 2016 Sep;12(9):504-17 |
SSID | ssj0000702638 |
Score | 2.1948903 |
SecondaryResourceType | review_article |
Snippet | Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent
,
and clinical studies... Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and... Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro , in vivo and... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 119 |
SubjectTerms | Biomarkers Diabetes mellitus Exosomes Metabolic syndrome X Review Standardization 소아과학 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2AooC4obTxI47dW4taFaRyolJvlh9jWLVNqs1W4uczk6SrXYTgwilKYkf257H9fbFnzNiHBJn8K1PFPYRKcUgV8jhTQYpaJZ2ksOTgfPZVn56rLxfNxcZRX7QnbAoPPAG332QThFdZyUD0vjGQdOuNjzEYqEOg0be29YaYGsfgFrXFeIy1QElQURCryWMG-Xqz72-AnNC53hN8T-KoYbdmpTF4P8413TL_iXf-vn1yYz46ecQezkSyPJwq8Jjdg-4Ju382L5U_ZQfHP_uhv4ah9EOJLK-cftOXfS7J5Z525SwHuruGFRrC1SKW82LN8Iydnxx_-3RazQclVLFppK18brOxkFOTAULC6UZKEVFw5qyQ7pikgEdrAm-NApu0TrReqZC61ZhNZ_mc7XR9By9Z6UHXKpvsUUapBNy3-Gmus8-WA46qBeN3QLk4RxGnwyyuHKoJAtcRuI7AdYI7iQrDFuzjOs_NFEPjr6mPCP91Sop_PT5Aq3CzVbh_WUXB3mPrucu4GPPT9XvvLpcOVcJnUj1CcFmwd3eN67BT0UqJ76C_HRwCiMAilzIFezE19ro8om0pRiPmbrfMYKvA22-6xY8xcDdyb8mb9tX_qOFr9oBgm7a7vWE7q-Ut7CI_WoW3Y1f4BUEbDGQ priority: 102 providerName: Directory of Open Access Journals |
Title | Exosomes as the source of biomarkers of metabolic diseases |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27777903 https://www.proquest.com/docview/1835535098 https://pubmed.ncbi.nlm.nih.gov/PMC5073157 https://doaj.org/article/5f8b2a4f43b042858ed67a8accb8e0bb https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002152674 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Annals of Pediatric Endocrinology & Metabolism, 2016, 21(3), , pp.119-125 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKkRAXRHkGShUQN5Rl_YjjcKkoalWQlhMr9WY59risuk1KspXKv2cmya5YVBCnKA8n0efHfJ_tmWHsbYBI_pUh4w6qTHEIGfI4k0HwWgUdpCjJwXn2VZ_O1Zez_GyHrdMdjQB2t0o7yic1b5eTmx8_D7HDI3-dIP3O37srIJ9yrieCTyQOAuUddhctkyYxNhvpfj8yF6g4-uTWAoVCRqGtBj-av7xmy1b1If3RAtVtvI2N_rmp8jcrdfKQPRjpZfpxaA97bAfqR-zebFxAf8w-HN80XXMJXeq6FLlfOkzep01MyRGf9uq0HZ1dwgqbx3Lh03EJp3vC5ifH3z6dZmP6hMznuSwzF4toSoghjwBVQCMkpfAoQ2NUSIJMUMB9aSpeGAVl0DrQKqZCQjfFYjrKp2y3bmp4zlIHeqqiiQ7FlQrAXYGv5jq6WHLAsTZhfA2U9WNscUpxsbSoMQhcS-BaAtcKbiXqjjJh7zZlrobIGv98-ojw3zxJUbH7C017bsdOZvNoKuFUVLIiKZgbCLpwxnlfGZhWVcLeYO3ZC7_oy9PxvLEXrUXt8Jm0kBBcJuz1unItdjVaP3E1NNedRQARWGRYJmHPhsre_I8oCorciKWLrWaw9cPbd-rF9z6cNzJyyfPixX989yW7T6gMe9z22e6qvYZXSIpW1UE_mXDQt_dfZJ4Jdg |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosomes+as+the+source+of+biomarkers+of+metabolic+diseases&rft.jtitle=Annals+of+pediatric+endocrinology+%26+metabolism&rft.au=Lee%2C+Min-Jae&rft.au=Park%2C+Dong-Ho&rft.au=Kang%2C+Ju-Hee&rft.date=2016-09-01&rft.issn=2287-1012&rft.volume=21&rft.issue=3&rft.spage=119&rft_id=info:doi/10.6065%2Fapem.2016.21.3.119&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-1012&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-1012&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-1012&client=summon |